Home ยป Stroke

Stroke

Beaumont, Royal Oak, is proud to have earned designation as a Primary Stroke Center by The Joint Commission, the nation's predominant accrediting organization in health care. After passing a rigorous on-site review and examination of patient care, Beaumont has been recognized as:

  • Providing high-quality medical care that follows national, evidence-based standards
  • Meeting the specialized needs of stroke patients
  • Making exceptional efforts to foster better outcomes

This designation is considered a "seal of approval" and recognizes the exceptional efforts of the Beaumont stroke care team at providing advanced care according to the latest stroke treatment standards.

Our certification affirms the success of our comprehensive stroke care, which includes:

  • More interventional stroke specialists on staff than any other hospital in Michigan
  • Is the only hospital in Oakland and Macomb counties with an emergency treatment team in the hospital 24/7 for complete interventional care for acute stroke and aneurysm patients any time day or night.
  • Dedicated intensive care beds for stroke patients
  • A dedicated neuroscience unit with 66 beds and nine monitored critical care beds
  • Specially trained and certified nursing staff
  • Interventional neurosurgeons and neuroradiologists who can administer intra-arterial t-PA and remove blood clots from the brain

Beaumont, Royal Oak, treats more stroke patients than any other hospital in the state of Michigan.

The neurovascular program manages all aspects of stroke and cerebrovascular disorders and coordinates subsequent therapeutic strategies including surgery, interventional neuroradiology, stereotactic radiosurgery, and rehabilitation.

Our goal is to provide comprehensive, individualized care that will help our patients recover to achieve the best quality of life possible.

Research

The cornerstone of being a Primary Stroke Center is a dedication to evidence-based medicine. Our team of experts works together on a wide range of stroke research projects -- from studies of new medicines to prevent stroke to developing advanced surgical procedures to improve blood flow to the brain after stroke. In addition, our team maintains a stroke registry in an effort to improve best practices for stroke care.

Beaumont participated in a recent national study that showed the effectiveness of a new heart-filtering device in preventing strokes.

Beaumont is also involved in a pivotal trial to demonstrate the safety and efficacy of the Coaxia NeuroFlo catheter as a treatment for ischemic stroke.  The trial, called SENTIS (Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke) will determine if this unique method for increasing blood flow to the brain (with a catheter partially occluding the aorta) can minimize the damage caused by stroke and improve patient outcome in patients up to 14 hours after the onset of their stroke.